Vertex Pharmaceuticals (VRTX) Net Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 453.08% |
| Dec 31, 2025 | 121.11% |
| Sep 30, 2025 | -104.75% |
| Jun 30, 2025 | 105.23% |
| Mar 31, 2025 | 106.97% |
| Dec 31, 2024 | 18.54% |
| Sep 30, 2024 | -35.65% |
| Jun 30, 2024 | -639.74% |
| Mar 31, 2024 | 3.35% |
| Dec 31, 2023 | -159.63% |
| Sep 30, 2023 | 92.86% |
| Jun 30, 2023 | -24.71% |
| Mar 31, 2023 | -251.69% |
| Dec 31, 2022 | 146.61% |
| Sep 30, 2022 | 134.88% |
| Jun 30, 2022 | 558.10% |
| Mar 31, 2022 | 146.89% |
| Dec 31, 2021 | -13.98% |
| Sep 30, 2021 | -58.08% |
| Jun 30, 2021 | -119.98% |
| Mar 31, 2021 | -32.78% |
| Dec 31, 2020 | 310.70% |
| Sep 30, 2020 | 389.07% |
| Jun 30, 2020 | 207.20% |
| Mar 31, 2020 | 100.25% |
| Dec 31, 2019 | -267.73% |
| Sep 30, 2019 | -68.18% |
| Jun 30, 2019 | 159.76% |
| Mar 31, 2019 | -27.60% |
| Dec 31, 2018 | -38.34% |
| Sep 30, 2018 | 242.06% |
| Jun 30, 2018 | -35.05% |
| Mar 31, 2018 | 282.06% |
| Dec 31, 2017 | -32.61% |
| Sep 30, 2017 | -14.47% |
| Jun 30, 2017 | 5,381.48% |
| Mar 31, 2017 | -63.38% |
| Dec 31, 2016 | 1,115.53% |
| Sep 30, 2016 | 200.58% |
| Jun 30, 2016 | -97.88% |
| Mar 31, 2016 | -368.01% |
| Dec 31, 2015 | 55.35% |
| Sep 30, 2015 | -137.76% |
| Jun 30, 2015 | 4,511.27% |
| Mar 31, 2015 | 128.96% |
| Dec 31, 2014 | -472.59% |
| Sep 30, 2014 | 514.75% |
| Jun 30, 2014 | -103.05% |
| Mar 31, 2014 | -33.10% |
| Dec 31, 2013 | -130.44% |
| Sep 30, 2013 | 385.23% |
| Jun 30, 2013 | -18.37% |
| Mar 31, 2013 | 47.16% |
| Dec 31, 2012 | 178.33% |
| Sep 30, 2012 | -120.28% |
| Mar 31, 2012 | -202.12% |
| Dec 31, 2011 | 79.44% |
| Sep 30, 2011 | -63.63% |
| Mar 31, 2011 | 505.46% |
| Dec 31, 2010 | -192.85% |
| Sep 30, 2010 | 53.21% |
| Jun 30, 2010 | 69.17% |
| Mar 31, 2010 | -123.47% |